Michael Sardano, PRESIDENT AND GENERAL COUNSEL at Sensus Healthcare, Inc. (SRTS), sold 5,000 shares at $14.13 ($71K) on 2022-09-13, disclosed to the SEC on 2022-09-15.
Open-market sale of $71k SRTS by PRESIDENT AND GENERAL COUNSEL. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SRTS | BUY | 2025-11-13 | $992 | — | Filing → |
| SRTS | BUY | 2025-08-14 | $3K | — | Filing → |
| SRTS | BUY | 2025-02-10 | $6K | — | Filing → |